;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Bio Blast Pharma amends IPO

    Bio Blast Pharma Ltd., Tel Aviv, Israel Business: Musculoskeletal Date announced: 2014-07-15 Type: IPO To be raised: Up to $43.3 million Shares: 3.3 million Price: $11-$13 Underwriters: Oppenheimer; Roth Capital …

    Published on 7/21/2014
  • Catalent amends IPO

    Catalent Inc., Somerset, N.J. Business: Supply/Service Date announced: 2014-07-18 Type: IPO To be raised: Up to $935 million Shares: 42.5 million Price: $19-$22 Underwriters: JPMorgan; Morgan Stanley; BofA Merrill Lynch…

    Published on 7/21/2014
  • CymaBay amends follow-on

    CymaBay Therapeutics Inc. (NASDAQ:CBAY), Newark, Calif. Business: Endocrine/Metabolic Date announced: 2014-07-17 Type: Follow-on To be raised: TBD Shares: 3.5 million Price prior: $7 Underwriters: Cowen; Stifel, …

    Published on 7/21/2014
  • Immune Design amends IPO

    Immune Design Corp., Seattle, Wash. Business: Infectious, Cancer Date announced: 2014-07-14 Type: IPO To be raised: Up to $65.1 million Shares: 4.7 million Price: $12-$14 Underwriters: Jefferies; Leerink Partners; Wells…

    Published on 7/21/2014
  • Innocoll amends IPO

    Innocoll GmbH, Athlone, Ireland Business: Drug delivery, Neurology, Infectious Date announced: 2014-07-15 Type: IPO To be raised: Up to $80.3 million Shares: 5.4 million Price: $13-$15 Underwriters: Piper Jaffray; …

    Published on 7/21/2014
  • Marinus amends IPO

    Marinus Pharmaceuticals Inc., New Haven, Conn. Business: Neurology Date announced: 2014-07-18 Type: IPO To be raised: Up to $56 million Shares: 4 million Price: $12-$14 Underwriters: Stifel, Nicolaus & Co.; JMP …

    Published on 7/21/2014
  • Microlin Bio amends IPO

    Microlin Bio Inc., New York, N.Y. Business: Cancer Date announced: 2014-07-15 Type: IPO To be raised: Up to $30.3 million Units: 5.5 million Price: $4.50-$5.50 (unit) Underwriters: Brean Capital; Summer Street; Meyers …

    Published on 7/21/2014
  • Pfenex amends IPO

    Pfenex Inc., San Diego, Calif. Business: Biosimilars, Supply/Service Date announced: 2014-07-17 Type: IPO To be raised: $65 million Shares: 8.1 million Price: $8 Underwriters: William Blair; JMP Securities; Mizuho …

    Published on 7/21/2014
  • Zosano amends IPO

    Zosano Pharma Corp., Fremont, Calif. Business: Drug delivery Date announced: 2014-07-16 Type: IPO To be raised: Up to $76.8 million Shares: 6.4 million Price: $10-$12 Underwriters: Wedbush; Ladenburg Thalmann; Roth …

    Published on 7/21/2014
  • amcure completes venture financing

    amcure GmbH, Eggenstein-Leopoldshafen, Germany Business: Cancer Date completed: 2014-07-15 Type: Venture financing Raised: EUR5 million ($6.8 million) Investors: LBBW Venture Capital; KfW; MBG Baden-Wuerttemberg; S-Kap …

    Published on 7/21/2014
  • Edico Genome completes venture financing

    Edico Genome Inc., La Jolla, Calif. Business: Genomics Date completed: 2014-07-17 Type: Venture financing Raised: $10 million Investors: Qualcomm Ventures; Axon Ventures; and an individual investor

    Published on 7/21/2014
  • Medigene completes convertible bond financing

    Medigene AG (Xetra:MDG), Martinsried, Germany Business: Cancer, Autoimmune, Infectious Date completed: 2014-07-15 Type: Convertible bond financing Raised: EUR818,658 ($1.1 million) Shares outstanding prior: 13.9 million…

    Published on 7/21/2014
  • Medigene completes private placement

    Medigene AG (Xetra:MDG), Martinsried, Germany Business: Cancer, Autoimmune, Infectious Date completed: 2014-07-15 Type: Private placement Raised: EUR15.1 million ($20.6 million) Shares: 3 million Price: EUR5 Shares …

    Published on 7/21/2014
  • Merus Labs International completes private placement of convertible preferred stock

    Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario Business: Infectious, Dermatology Date completed: 2014-07-11 Type: Private placement of convertible preferred stock Raised: C$10 million ($9.3 …

    Published on 7/21/2014
  • Oncobiologics completes venture financing

    Oncobiologics Inc., Cranbury, N.J. Business: Supply/Service Date completed: 2014-07-16 Type: Venture financing Raised: Not disclosed Investor: Strides Arcolab Ltd. Note: The company said it has received an undisclosed …

    Published on 7/21/2014
  • Phosphagenics completes private placement

    Phosphagenics Ltd. (ASX:POH; OTCQX:PPGNY), Melbourne, Australia Business: Drug delivery, Neurology Date completed: 2014-07-11 Type: Private placement Raised: A$12.2 million ($11.5 million) Shares: 153 million Price: A$0…

    Published on 7/21/2014
  • RestorGenex completes private placement of units

    RestorGenex Corp. (OTCQB:RESX), Los Angeles, Calif. Business: Cancer, Dermatology, Ophthalmic Date completed: 2014-07-14 Type: Private placement of units Raised: $35.6 million Units: 8.9 million Price: $4 (unit) Shares …

    Published on 7/21/2014
  • StemCells completes private placement of units

    StemCells Inc. (NASDAQ:STEM), Newark, Calif. Business: Gene/Cell therapy, Neurology Date completed: 2014-07-18 Type: Private placement of units Raised: $20 million Units: 11.3 million Price: $1.77 (unit) Shares after …

    Published on 7/21/2014
  • ZS Pharma completes debt financing

    ZS Pharma Inc. (NASDAQ:ZSPH), Coppell, Texas Business: Renal, Hepatic, Cardiovascular Date completed: 2014-07-17 Type: Debt financing Raised: $10 million Investor: MidCap Financial Note: The company drew down $10 …

    Published on 7/21/2014
  • Actinium financial update

    Actinium Pharmaceuticals Inc. (NYSE-M:ATNM), New York, N.Y. Business: Cancer Date announced: 2014-07-10 Note: Actinium raised $1.2 million through the sale of 157,123 shares at $7.50 to cover the overallotment from its …

    Published on 7/21/2014
  • Auspex financial update

    Auspex Pharmaceuticals Inc. (NASDAQ:ASPX), La Jolla, Calif. Business: Chemistry, Neurology Date announced: 2014-07-16 Note: Auspex raised $9.1 million through the sale of 472,500 shares at $19.25 to cover the …

    Published on 7/21/2014
  • Critical Outcome Technologies financial update

    Critical Outcome Technologies Inc. (TSX-V:COT; OTCQB:COTQF), London, Ontario Business: Cancer, Autoimmune, Infectious Date announced: 2014-07-16 Note: Critical Outcome extended the expiry date to Jan. 29, 2016, from …

    Published on 7/21/2014
  • immatics financial update

    immatics biotechnologies GmbH, Tuebingen, Germany Business: Cancer Date announced: 2014-07-16 Note: The company raised EUR22 million ($30 million) in the final tranche of a series D round, bringing the total raised in …

    Published on 7/21/2014
  • Ligand financial update

    Ligand Pharmaceuticals Inc. (NASDAQ:LGND), La Jolla, Calif. Business: Cancer, Inflammation Date announced: 2014-07-17 Note: Ligand said its board authorized a one-year share repurchase program of up to $10 million. The …

    Published on 7/21/2014
  • Medicure financial update

    Medicure Inc. (TSX-V:MPH; OTCQB:MCUJF), Winnipeg, Manitoba Business: Cardiovascular Date announced: 2014-07-11 Note: Medicure will issue 205,867 shares at C$1.98 to CEO Albert Friesen and company directors to satisfy …

    Published on 7/21/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993